Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Orthopediatrics (KIDS) Operating Income (2016 - 2025)

Historic Operating Income for Orthopediatrics (KIDS) over the last 10 years, with Q3 2025 value amounting to -$9.4 million.

  • Orthopediatrics' Operating Income fell 6938.56% to -$9.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$45.1 million, marking a year-over-year decrease of 5547.71%. This contributed to the annual value of -$35.0 million for FY2024, which is 3087.36% down from last year.
  • According to the latest figures from Q3 2025, Orthopediatrics' Operating Income is -$9.4 million, which was down 6938.56% from -$10.7 million recorded in Q2 2025.
  • Over the past 5 years, Orthopediatrics' Operating Income peaked at -$2.8 million during Q2 2021, and registered a low of -$14.1 million during Q4 2024.
  • For the 5-year period, Orthopediatrics' Operating Income averaged around -$7.2 million, with its median value being -$6.4 million (2022).
  • In the last 5 years, Orthopediatrics' Operating Income surged by 5944.14% in 2021 and then tumbled by 9102.63% in 2022.
  • Orthopediatrics' Operating Income (Quarter) stood at -$5.6 million in 2021, then crashed by 49.42% to -$8.3 million in 2022, then grew by 2.92% to -$8.1 million in 2023, then plummeted by 74.25% to -$14.1 million in 2024, then surged by 32.92% to -$9.4 million in 2025.
  • Its last three reported values are -$9.4 million in Q3 2025, -$10.7 million for Q2 2025, and -$11.0 million during Q1 2025.